About Genomate Health
Genomate Health is a private company based in Cambridge, Massachusetts, incorporated in 2022 in Delaware. It has reported $10,390,000 raised in three offerings on Form D since February 2025. Its chief executive is Istvan Petak.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2025 | Mar 12, 2025 | $2,000,000fully sold | 1 | $2.0M | SIMPLE AGREEMENT FOR FUTURE EQUITY (SAFE)Rule 506(b) | Form D ↗ |
| Oct 10, 2023 | Feb 11, 2025 | $2,650,000fully sold | 4 | $662K | SIMPLE AGREEMENT FOR FUTURE EQUITY (SAFE)Rule 506(b) | Form D ↗ |
| Oct 28, 2022 | Feb 11, 2025 | $5,740,000fully sold | 7 | $820K | Simple Agreement for Future Equity (SAFE)Rule 506(b) | Form D ↗ |
| Total, three offerings | $10,390,000 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Genomate Health's Form D filed Mar 12, 2025.
RS
Richard Schwab
Director
JS
Jared Schrieber
Director
IP
Istvan Petak
Chief Executive Officer and director
SF
Scott Friedman
Director
LM
Laszlo Mechtler
Director